Figure 1
Figure 1. Strategy of flow cytometry analysis of immunostained whole blood and marrow samples (from MGUS and MM patients). Gating was done sequentially on live cells, on lineage-negative cells, and then on CD11c+HLA-DRhi cells or BDCA-1/BDCA-3+HLA-DRhi cells to identify mDCs and on CD123+HLA-DR+ cells or BDCA-2+HLA-DR+ to identify pDCs. Representative plots from 1 patient for each group.

Strategy of flow cytometry analysis of immunostained whole blood and marrow samples (from MGUS and MM patients). Gating was done sequentially on live cells, on lineage-negative cells, and then on CD11c+HLA-DRhi cells or BDCA-1/BDCA-3+HLA-DRhi cells to identify mDCs and on CD123+HLA-DR+ cells or BDCA-2+HLA-DR+ to identify pDCs. Representative plots from 1 patient for each group.

Close Modal

or Create an Account

Close Modal
Close Modal